News
A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia.
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
After the baby has been delivered, the umbilical cord is clamped and about 2 to 3 ounces of the blood it contains are collected. The blood is then transferred to a specially prepared bag and sent ...
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...
Unlike type 1, type 2 diabetes can sometimes be prevented. According to the charity Diabetes UK, research has shown for some ...
At its core, diabetes mellitus is about your body’s relationship with insulin, the hormone responsible for helping cells ...
Normally, TGF-Beta soothes the immune system, and some cancers use it to evade attack. It also triggers a signaling cascade ...
Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...
Their findings revealed novel mechanisms: the immune system ... cells are genetically modified in the laboratory and then reintroduced into the body through infusion. The modified cells, known as CAR ...
Antibody treatments are a type of immunotherapy, which work by helping the body’s immune system to recognise and kill cancer cells. Almost all antibodies currently used in cancer treatment are made ...
The immune system works to maintain homeostasis throughout the body. Various cell types and immune mechanisms work in concert to fight disease. Specifically, two waves of immunity orchestrate a robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results